PDA

View Full Version : Testicular Cancer Research Library


  1. Long-Term Medical Care of Testicular Cancer Survivors
  2. The current status of laparoscopic RPLND for non-seminomatous germ-cell tumors
  3. Second Cancers Among 40,576 Testicular Cancer Patients: Focus on Long-term Survivors
  4. article from web md
  5. Mortality After Cure of Testicular Seminoma
  6. Radiation exposure from X-rays and CT scans
  7. 1 cycle of BEP for stage 1 Nonseminoma
  8. 2006 American Society of Clinical Oncology (ASCO) abstracts
  9. Paternity following treatment for testicular cancer
  10. Oestrogens
  11. Article and 2 editorials on carboplatin for stage 1 seminoma
  12. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma
  13. Article on Vit C
  14. heat kills
  15. Implications for TC
  16. Better tumor marker for Yolk Sac
  17. Sperm DNA integrity in testicular cancer patients
  18. Low-dose radiotherapy for Stage I seminoma-long-term results
  19. Two cycles of cisplatin-based chemo for low-volume stage II non-seminoma
  20. Predicting teratoma in the retroperitoneum in men undergoing post-chemo RPLDN
  21. Quality of life after lap. and open RPLND in stage I nonseminoma
  22. Treating stage I nonseminomatous germ cell tumours with a single cycle of chemo
  23. Late relapse of metastatic testicular nonseminoma: surgery is needed for cure
  24. Incidence of testicular germ cell cancers in U.S. children
  25. High-dose chemo with HSC in patients with poor prognosis, relapsed or refractory TC
  26. short- and long-term effects of chemo- or radiotherapy on spermatogenesis
  27. Advances in the treatment of testicular cancer
  28. Management of Stage I Testis Cancer
  29. see your tumor
  30. Treatment of stage I seminoma: a 15-year review
  31. Excellent Review
  32. PET scans in postchemo seminoma patients with residual masses
  33. Controversies in the management of clinical stage I testis cancer
  34. Late Relapses of Germ Cell Malignancies: Incidence, Management, and Prognosis
  35. Metabolic clues regarding the enhanced performance of elite endurance athletes from o
  36. Phase II study of cisplatin plus epirubicin salvage chemotherapy in refractory germ c
  37. Familial testicular cancer: Interest in genetic testing among high-risk family member
  38. Transient neurological adverse effects following low dose RT for early
  39. Use of cellular and cordless telephones and risk of testicular cancer
  40. Cervical mature teratoma 17 years after initial treatment of testicular teratocarcino
  41. Long-term results of radiotherapy for early-stage testicular seminoma
  42. Laparoscopic and open RPLND for clinical stage I nonseminoma
  43. Concurrent development of testicular seminoma and choriocarcinoma of the superior med
  44. DCA Treatment of Cancer Cells
  45. Mortality and incidence of second cancers following treatment for testicular cancer.
  46. Long-Term Clinical Outcome After Postchemo RPLND in Men with Residual Teratoma
  47. Phase III Trial of Chemo +/- HDC & stem cell rescue as 1st line treatment
  48. Postchemotherapy Retroperitoneal Surgery Remains Necessary in Patients ..............
  49. Incidence of Disease Outside Modified RPLND Templates in Stage I or IIA Nonseminoma
  50. Does the presence of extranodal extension in pIB nonsem. necessitate adjuvant chemo?
  51. Vitamin E for Protection Against Peripheral Neuropathy
  52. Canadian radiation oncologists surveyed prefer surveillance for stage I seminoma
  53. Long-term results of laparoscopic RPLND for clinical
  54. Phase II study paclitaxel +gemcitabine salvage after progression following HDC w/TT
  55. Management of recurrent testicular germ cell tumors
  56. TC Cure Rate North-South
  57. Long-term clinical outcome after postchemo RPLND in men with residual teratoma
  58. Failure of high-dose cyclophosphamide and etoposide combined with double-dose cisplat
  59. Long-term outcome of stage I seminoma.
  60. Evidence-based guidelines for following stage 1 seminoma
  61. Rate Your Doctor Online!
  62. Chemo Brain
  63. Surgical management of growing teratoma syndrome:the M.D.Anderson CC experience
  64. Bacterially Derived 400 nm Particles for Encapsulation and Cancer Cell Targeting of C
  65. Randomized trial of 2 or 5 CT scans in the surveil. of stage 1 NSGC
  66. Hypogonadism and androgen deficiency symptoms in testicular cancer survivors.
  67. Embryonic stem cell transcription factor signatures in the diagnosis of primary and m
  68. High-Dose Chemotherapy and Stem-Cell Rescue for Metastatic Germ-Cell Tumors
  69. A risk-adapted approach to the treatment of stage I seminoma
  70. Lymphoma question
  71. The Value of the the Rate of Decline of AFP and HCG
  72. Predicting retroperitoneal histology in postchemotherapy testicular germ cell cancer
  73. Testicular Cancer research funded by LAF
  74. Abstract Is full bilateral retroperitoneal lymph node dissection always necessary for
  75. Testicular cancer rise in the US
  76. Short-term morbidity of primary RLND in a contemporary group of patients.
  77. Complications of post-chemotherapy retroperitoneal lymph node dissection
  78. Chewing gum may speed recovery after bowel surgery, research suggests.
  79. Scientists Discover New Molecular Markers For Testicular Cancer
  80. Hand-Assisted L-RPLND
  81. L-RPLND with waterjet
  82. The Dose of etoposide in initial treatment of relapsed GCT
  83. Recent Article Cleveland Clinic
  84. Machine Built In Garage May Cure Cancer
  85. Palonosetron plus dex for prevention of chemo-induced nausea and vomiting
  86. Phase I/II study of sequential dose-intensified VIP plus paclitaxel as induction ther
  87. Bleomycin and scuba diving: where is the harm?
  88. Nonrandomized comparison of primary chemo and RPLND for stage IIA and IIB nonseminom
  89. Improved clinical outcome in recent years for men with metastatic nonseminomatous ger
  90. A pitfall of 18-fluorodeoxyglucose-PET in a patient with a tattoo.
  91. The long-term risks of adjuvant carboplatin treatment for stage I seminoma of the tes
  92. Two cycles of etoposide/cisplatin cured all patients with stage I testicular seminoma
  93. Oncologic efficacy of L-RPLND in treatment of clinical stage I nonseminoma
  94. TC Clincial Trials in the UK
  95. A Comprehensive Systematic Review of Testicular Germ Cell Tumor Surveillance
  96. Abstract: Role of Impaired Gonadal Development
  97. Medical Treatment of Advanced Testicular Cancer
  98. ASCO 2008 Papers: Stage 1 Seminoma and Non-Seminoma
  99. Testicular Microlithiasis...Relationship to Testicular Tumors
  100. Testicular Microlithiasis as a Familial Risk Factor
  101. Combination carboplatin and radiotherapy in the management of stage II seminoma
  102. Hereditary persistance of AFP
  103. NCCN Guidelines
  104. lrplnd
  105. Microlithiasis Followup Study Abstract
  106. HD Chemo & Stem Cell Rescue - Abstract
  107. Testicular Tumors - Some New and a Few Perennial Problems - Abstract
  108. Complications of 2,775 Urological Laparoscopic Procedures: 1993 to 2005
  109. Management of the Retroperitoneum after Chemotherapy in Testicular Cancer:
  110. Genetic Variation in Hormone Metabolizing Genes.....-Abstract
  111. Visualization L-RPLND after Patent Blue Dye Injection
  112. Organochlorine Pesticides and Risk of TGC Tumors-Abstract
  113. The indication for postchemotherapy lymph node dissection in clinical stage IS nonsem
  114. Variation in bleomycin hydrolase gene is associated with reduced survival after chemo
  115. Radiotherapy versus carboplatin for stage I seminoma: Updated analysis of the MRC/EOR
  116. Flavopiridol Clinic trial at MSKCC
  117. Gemcitabine and oxaliplatin (GEMOX) in patients with cisplatin-refractory GCT
  118. FDA Launches “Fake Cancer Cures” Website
  119. Treatment Options for Management of StageI Seminoma
  120. Management of Stage I Seminoma: Guideline Recommendations
  121. Management of Stage I Nonseminomatous Testicular Cancer
  122. Complications of L-RPLND
  123. Very Interesting Chart
  124. GAMEC - a new intensive protocol for untreated poor prognosis and relapsed or refract
  125. BEP vs. RPLND for Stage 1 Non-Seminoma (editorial)
  126. CT vs X-Ray
  127. Adjuvant Radiation Stage 1 Seminoma-Abstract
  128. Pharmacotherapy of Relapsed Metastatic Testicular Cancer - Abstract
  129. Salvage Chemotherapy after Failure of First-Line Chemotherapy in Patients with Metast
  130. Updated NCCN Guidelines for TC Published (v.1.2009)
  131. Cancer Risk in Male Factor-Infertility - Abstract
  132. Complete response after imatinib mesylate administration for stage IV Seminoma
  133. Common weed killers cause work cancers
  134. Serum Organochlorine Pesticide Residues and Risk of TGCC: Abstract
  135. Pesticides study "08 and a thought
  136. Adjuvant Therapies for Seminoma Stage I
  137. Biology of Testicular Germ Cell Tumors - Abstract
  138. Robotic Surgery Article
  139. Searching - Testicular Cancer on Cuil.com
  140. UK treatment guidelines in great detail
  141. Gestational Hypertension, Preeclampsia, and Risk of Testicular Cancer - Abstract
  142. Risk of Contralateral TC Among Men with Unilaterally Undescended Testis - Abstract
  143. Chemotherapy As Alternative to Radiotherapy..for..Stage IIA & IIB Seminoma -Abstract
  144. New Platinum-phosphate Compounds Kill Ovarian Cancer Cells, Other Cancer Cells